Ki-67 expression of tumor-infiltrating lymphocytes serves as a prognostic factor in Luminal-B breast cancer patients with residual disease after neoadjuvant chemotherapy

Wang R. -X.; Chen S.; Shao Z. -M.

首页> 外文期刊>The Breast : >Ki-67 expression of tumor-infiltrating lymphocytes serves as a prognostic factor in Luminal-B breast cancer patients with residual disease after neoadjuvant chemotherapy

【24h】

Ki-67 expression of tumor-infiltrating lymphocytes serves as a prognostic factor in Luminal-B breast cancer patients with residual disease after neoadjuvant chemotherapy

机译：肿瘤浸润淋巴细胞的表达是Neoadjuvant化疗后患有腔B乳腺癌患者的预后因素

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast :》 |2019年第1期|共2页
作者
Wang R. -X.; Chen S.; Shao Z. -M.;
展开▼
作者单位

Fudan Univ Shanghai Canc Ctr Shanghai Peoples R China;

Fudan Univ Shanghai Canc Ctr Shanghai Peoples R China;

Fudan Univ Shanghai Canc Ctr Shanghai Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Ki-67 expression of tumor-infiltrating lymphocytes serves as a prognostic factor in Luminal-B breast cancer patients with residual disease after neoadjuvant chemotherapy [J] . Wang R. -X., Chen S., Shao Z. -M. The Breast : . 2019,第Suppla1期

机译：肿瘤浸润淋巴细胞的表达是Neoadjuvant化疗后患有腔B乳腺癌患者的预后因素
2. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy [J] . Yu-Ge Bai, Guo-Xuan Gao, Hong Zhang, 中华医学杂志（英文版） . 2020,第005期

机译：肿瘤浸润淋巴细胞亚型在三阴性乳腺癌新辅助化疗后残留肿瘤中的预后价值
3. Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer [J] . Sasagu Kurozumi, Kenichi Inoue, Hiroshi Matsumoto, Scientific reports. . 2019,第1期

机译：曲妥珠单抗新辅助化疗后肿瘤浸润淋巴细胞在残留肿瘤中对HER2阳性乳腺癌的预后作用
4. Prognostic Significance of COX-2 and VEGF in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy [C] . Gang-Ping WANG, Xue WANG, Zhao-Jun DING, International Conference on Biological Sciences and Technology . 2016

机译：Cox-2和VEGF在接受新辅助化疗的乳腺癌患者中的预后意义
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy [O] . Yu-Ge Bai, Guo-Xuan Gao, Hong Zhang, 2020

机译：肿瘤浸润淋巴细胞亚型在三阴性乳腺癌新辅助化疗后残留肿瘤中的预后价值
7. Prognostic significance of tumor-infiltrating CD8 and FOXP3 lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study [O] . 2015

机译：三阴性乳腺癌新辅助化疗后残留肿瘤中浸润性CD8和FOXP3淋巴细胞的预后意义以及这些参数的改变：一项回顾性多中心研究

Ki-67 expression of tumor-infiltrating lymphocytes serves as a prognostic factor in Luminal-B breast cancer patients with residual disease after neoadjuvant chemotherapy

著录项

相似文献

相关主题

期刊订阅